These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 35141256)

  • 21. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transforming growth factor-beta/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension.
    Zakrzewicz A; Kouri FM; Nejman B; Kwapiszewska G; Hecker M; Sandu R; Dony E; Seeger W; Schermuly RT; Eickelberg O; Morty RE
    Eur Respir J; 2007 Jun; 29(6):1094-104. PubMed ID: 17392319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
    Morrell NW
    Proc Am Thorac Soc; 2006 Nov; 3(8):680-6. PubMed ID: 17065373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pulmonary arterial hypertension and BMP system abnormality].
    Otsuka F
    Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension.
    Ryanto GRT; Musthafa A; Hara T; Emoto N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension.
    Sharmin N; Nganwuchu CC; Nasim MT
    Trends Pharmacol Sci; 2021 Jul; 42(7):510-513. PubMed ID: 33966900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
    Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
    Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension.
    Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
    Li YX; Run L; Shi T; Zhang YJ
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
    Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
    Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential of asiaticoside for TGF-β1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension.
    Wang XB; Wang W; Zhu XC; Ye WJ; Cai H; Wu PL; Huang XY; Wang LX
    Life Sci; 2015 Sep; 137():56-64. PubMed ID: 26209140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
    Hadri L; Kratlian RG; Benard L; Maron BA; Dorfmüller P; Ladage D; Guignabert C; Ishikawa K; Aguero J; Ibanez B; Turnbull IC; Kohlbrenner E; Liang L; Zsebo K; Humbert M; Hulot JS; Kawase Y; Hajjar RJ; Leopold JA
    Circulation; 2013 Jul; 128(5):512-23. PubMed ID: 23804254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.
    Aldred MA; Morrell NW; Guignabert C
    Circ Res; 2022 Apr; 130(9):1365-1381. PubMed ID: 35482831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.
    Kumar R; Mickael C; Chabon J; Gebreab L; Rutebemberwa A; Garcia AR; Koyanagi DE; Sanders L; Gandjeva A; Kearns MT; Barthel L; Janssen WJ; Mauad T; Bandeira A; Schmidt E; Tuder RM; Graham BB
    Am J Respir Crit Care Med; 2015 Oct; 192(8):998-1008. PubMed ID: 26192556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor.
    Davies RJ; Morrell NW
    Chest; 2008 Dec; 134(6):1271-1277. PubMed ID: 19059957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.
    Upton PD; Morrell NW
    Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.